Adma Biologics (ADMA) Amortization of Deferred Charges (2013)
Adma Biologics' (ADMA) quarterly Amortization of Deferred Charges came in at $20640.0 in Q1 2013.
Powered by 
Analysis
Adma Biologics (ADMA) Amortization of Deferred Charges (2013) Analysis & Trends
Adma Biologics (ADMA) has 1 years of Amortization of Deferred Charges data on file, last reported at $20640.0 in Q1 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Adma Biologics | 2.18 Bn | 2.04 Bn | 86.28 Mn |